The expression of human tau containing the most common FTDP-17-related mutations (either P301S or P301L) results in motor and cognitive deficits in transgenic mice with the age- and gene dose-dependent development of NFTs [64]. This evidence concerns the gene MAPT and Cognitive impairment.